TickerFactsScreenerDevelopers

BioXcel Therapeutics, Inc. (BTAI) — Cash & Equivalents

Annual figures by fiscal year, from SEC filings.

2017: $887.0K2018: $42.56M2019: $32.43M2020: $213.12M2021: $232.97M2022: $193.72M2023: $65.22M2024: $29.85M2025: $28.41M$28.41M
2017Cash & Equivalents (USD)2025
Fiscal YearCash & EquivalentsChange YoY
2025$28.41M-4.8%
2024$29.85M-54.2%
2023$65.22M-66.3%
2022$193.72M-16.8%
2021$232.97M+9.3%
2020$213.12M+557.2%
2019$32.43M-23.8%
2018$42.56M+4698.8%
2017$887.0K—